Literature DB >> 28306321

Eosinophilia, Frequent Exacerbations, and Steroid Response in Chronic Obstructive Pulmonary Disease.

Peter M A Calverley1, Kay Tetzlaff2,3, Claus Vogelmeier4, Leonardo M Fabbri5, Helgo Magnussen6, Emiel F M Wouters7, William Mezzanotte2, Bernd Disse2, Helen Finnigan8, Guus Asijee2, Christoph Hallmann2, Henrik Watz6.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28306321     DOI: 10.1164/rccm.201612-2525LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  32 in total

1.  New Treatment Options for COPD: How Do We Decide Phenotypes, Endotypes or Treatable Traits?

Authors:  Ron Balkissoon
Journal:  Chronic Obstr Pulm Dis       Date:  2018-01-18

2.  Journal Club: Inhaled Corticosteroids- Refining Our Understanding of Their Role in Maintenance Treatment for COPD.

Authors:  Ron Balkissoon
Journal:  Chronic Obstr Pulm Dis       Date:  2017-01-05

3.  The COPD Pipeline XXXV.

Authors:  Nicholas Gross
Journal:  Chronic Obstr Pulm Dis       Date:  2017-07-05

4.  Long-term oxygen treatment need is less frequent in eosinophilic COPD patients.

Authors:  Nilüfer Aylin Acet-Öztürk; Asli G Dilektasli; Özge Aydın-Güçlü; Ezgi Demirdöğen; Funda Coşkun; Ahmet Ursavaş; Mehmet Karadağ; Esra Uzaslan
Journal:  Clin Respir J       Date:  2021-10-26       Impact factor: 1.761

Review 5.  A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease.

Authors:  Marc Miravitlles; Borja G Cosío; Aurelio Arnedillo; Myriam Calle; Bernardino Alcázar-Navarrete; Cruz González; Cristóbal Esteban; Juan Antonio Trigueros; José Miguel Rodríguez González-Moro; José Antonio Quintano Jiménez; Adolfo Baloira
Journal:  Respir Res       Date:  2017-11-28

Review 6.  Current appraisal of single inhaler triple therapy in COPD.

Authors:  Brian Lipworth; Chris RuiWen Kuo; Sunny Jabbal
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-09-28

7.  Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials.

Authors:  Dave Singh; Jadwiga A Wedzicha; Salman Siddiqui; Alberto de la Hoz; Wenqiong Xue; Helgo Magnussen; Marc Miravitlles; James D Chalmers; Peter M A Calverley
Journal:  Respir Res       Date:  2020-09-17

Review 8.  Blood Eosinophils as Biomarkers to Drive Treatment Choices in Asthma and COPD.

Authors:  Konstantinos Kostikas; Caterina Brindicci; Francesco Patalano
Journal:  Curr Drug Targets       Date:  2018       Impact factor: 3.465

9.  Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality.

Authors:  Olorunfemi A Oshagbemi; Frits M E Franssen; Dionne C W Braeken; Yvonne Henskens; Emiel F M Wouters; Anke-Hilse Maitland-van der Zee; Andrea M Burden; Frank de Vries
Journal:  Pharmacoepidemiol Drug Saf       Date:  2018-09-28       Impact factor: 2.890

10.  Real-world effectiveness of early intervention with fixed-dose tiotropium/olodaterol vs tiotropium in Japanese patients with COPD: a high-dimensional propensity score-matched cohort analysis.

Authors:  Shigeo Muro; Masaru Suzuki; Shuhei Nakamura; Jocelyn Ruoyi Wang; Elizabeth M Garry; Wataru Sakamoto; Sabrina de Souza
Journal:  Respir Res       Date:  2021-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.